Biological Convergence of Cancer Signatures-Reference-Cited by-同舟云学术

Biological Convergence of Cancer Signatures

Published:2009-02-20 Issue:2 Volume:4 Page:e4544
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Solé Xavier,Bonifaci Núria,López-Bigas Núria,Berenguer Antoni,Hernández Pilar,Reina Oscar,Maxwell Christopher A.,Aguilar Helena,Urruticoechea Ander,de Sanjosé Silvia,Comellas Francesc,Capellá Gabriel,Moreno Víctor,Pujana Miguel Angel

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity.;DS Nuyten;Semin Radiat Oncol,2008

2. Gene expression profiling in breast cancer.;SR Morris;Curr Opin Oncol,2007

3. Interpretation of microarray data in cancer.;S Michiels;Br J Cancer,2007

4. “Good Old” clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers.;P Eden;Eur J Cancer,2004

5. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.;YH Lin;Clin Cancer Res,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer;Breast Cancer Research;2024-09-13

2. ZNF92, an unexplored transcription factor with remarkably distinct breast cancer over-expression associated with prognosis and cell-of-origin;npj Breast Cancer;2022-08-29

3. An Evaluation of Gene Set Analysis for Biomarker Discovery with Applications to Myeloma Research;Frontiers of Biostatistical Methods and Applications in Clinical Oncology;2017

4. Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer;Nature Reviews Clinical Oncology;2016-11-22

5. Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer;Oncotarget;2015-10-30